Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Verastem Inc (NASDAQ:VSTM)

1.32
Delayed Data
As of Sep 29
 -0.04 / -2.94%
Today’s Change
1.05
Today|||52-Week Range
2.43
-29.03%
Year-to-Date
No recent news for Verastem Inc.

Today’s Trading

Previous close1.36
Today’s open1.36
Day’s range1.32 - 1.41
Volume103,584
Average volume (3 months)276,213
Market cap$50.3M
Dividend yield--
Data as of 3:57pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+22.22%
Earnings growth (this year)+41.74%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.49

Competitors

 Today’s
change
Today’s
% change
PTIEPain Therapeutics In...-0.12-10.62%
APVOAptevo Therapeutics ...-0.06-2.29%
CYTRCytRx Corp-0.01-1.34%
PLXProtalix Biotherapeu...+0.01+1.74%
Data as of 3:59pm ET, 09/29/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$0.00
Annual profit (last year)-$57.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert M. Forrester
Chief Operating Officer
Dan Paterson
Corporate headquarters
Needham, Massachusetts

Forecasts

Search for Jobs